The global clear aligners market is valued at $11.23 billion in 2026 and is expected to grow to $99.44 billion by 2034, expanding at a 31.34% CAGR. North America leads the market while Asia Pacific shows the fastest growth. Adults dominate by age segment, polyurethane leads by material type, and online distribution channels are expected to grow fastest. Key drivers include rising demand for aesthetic orthodontic solutions, technological advancements in 3D imaging and AI, and expanding access through digital platforms.
Henry Schein Inc (HSIC)
Common Stock · Currency in USD · XNAS
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.
Company Info
SIC5047
Composite FIGIBBG000BNMMJ3
CIK0001000228
IPONov 3, 1995
Sectorwholesale-medical, dental & hospital equipment & supplies
Highlights
Market Cap$8.48B
EPS$3.36
P/E Ratio19.45
Revenue$13.16B
Gross Profit$4.10B
Net Income$436.00M
Employees25,000
WSO114,704,121
Phone(631) 843-5500
Websitehttps://www.henryschein.com
Related Tickers
AMN
AMN Healthcare Services
$18.20 0.00%
WST
West Pharmaceutical Services, Inc.
$253.88 0.00%
NVST
Envista Holdings Corporation Common stock, $0.01 par value per share
$25.81 0.00%
IDXX
Idexx Laboratories Inc
$569.55 0.00%
AVNS
Avanos Medical, Inc.
$13.95 0.00%
BIO
Bio-Rad Laboratories, Inc.Class A
$279.99 0.00%
MMSI
Merit Medical Systems Inc
$67.70 0.00%
COO
The Cooper Companies, Inc. Common Stock
$70.17 0.00%
BRBR
BellRing Brands, Inc.
$16.62 0.00%
MASI
Masimo Corporation
$178.59 0.00%
Analysis
Share Price Chart
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Henry Schein Inc, comparing it to the performance of the S&P 500 index.
All prices have been adjusted for splits and dividends.
Returns By Period
Henry Schein Inc (HSIC) has returned -2.26% so far this year and 17.14% over the past 12 months. Looking at the last ten years, HSIC has achieved an annualized return of 0.88%, underperforming the Benchmark (SPY), which averaged 12.23% per year.
HSIC
1M-6.91%
6M10.87%
YTD-2.26%
1Y17.14%
5Y1.33%
10Y0.88%
Benchmark (SPY)
1M-3.85%
6M-2.35%
YTD-4.36%
1Y34.06%
5Y9.80%
10Y12.23%
Monthly Returns
The table below presents the monthly returns of Henry Schein Inc (HSIC) with color gradation from worst to best to easily spot seasonal factors.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -0.22% | 9.17% | -8.82% | 0.33% | ||||||||
| 2025 | 14.81% | -8.23% | -5.10% | -5.22% | 7.91% | 4.97% | -7.09% | 2.87% | -4.12% | -4.62% | 17.67% | 2.19% |
| 2024 | -0.48% | 2.11% | -1.24% | -7.84% | -0.06% | -7.62% | 11.62% | -2.60% | 3.57% | -2.98% | 9.99% | -10.06% |
| 2023 | 8.16% | -8.88% | 4.83% | -0.90% | -8.55% | 9.18% | -1.83% | -2.74% | -3.42% | -12.38% | 2.76% | 13.27% |
| 2022 | -2.70% | 14.33% | 1.76% | -7.88% | 5.64% | -11.46% | 3.13% | -5.74% | -9.63% | 2.99% | 17.98% | -2.11% |
| 2021 | -3.46% | -6.74% | 10.78% | 4.87% | 3.55% | -2.14% | 7.41% | -6.26% | 0.51% | -0.68% | -6.97% | 8.40% |
| 2020 | 2.60% | -12.24% | -17.17% | 7.68% | 13.28% | -3.82% | 17.27% | -3.70% | -11.45% | 7.53% | 1.02% | 2.56% |
| 2019 | 0.70% | -2.86% | 0.64% | 5.67% | 0.62% | 8.83% | -5.32% | -6.62% | 3.56% | -1.16% | 9.52% | -3.43% |
| 2018 | 7.56% | -12.00% | 3.42% | 13.55% | -8.70% | 4.13% | 9.52% | -1.82% | 10.04% | -2.90% | 7.42% | -12.95% |
| 2017 | 3.64% | 7.23% | -1.44% | 2.10% | 5.82% | -0.67% | -0.83% | -3.88% | -5.75% | -4.37% | -9.59% | -1.48% |
| 2016 | -1.89% | 2.88% | 1.98% | 2.29% | -9.38% | -0.57% | -7.77% | -0.20% | 1.66% |
Performance Indicators
The charts below present risk-adjusted performance metrics for Henry Schein Inc (HSIC) and compare them to a Benchmark (SPY). These indicators evaluate an investment's returns against its associated risks.
Sharpe ratio
Sortino ratio
Omega ratio
Calmar ratio
Martin ratio
sharpe ratio
The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.
These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns.
The chart below shows the rolling Sharpe ratio of HSIC compared to the benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.
Volatility Chart
The current Henry Schein Inc volatility is 1.47%, representing the standart deviation of percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. It shows the maximum percentage drop from a peak to a trough over a specified period, indicating the risk of significant losses.
Although chart shows positive values, it represents the percentage drop from the peak, so a value of 10% means the portfolio has dropped 10% from its highest point.
Income Statement
The income statement provides a summary of a company's revenues, expenses, and profits over a specific period. It shows how much money the company earned (revenues) and how much it spent (expenses), leading to the net income or profit. This statement is crucial for understanding a company's financial performance and profitability.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities And Equity (USD) | 10.22B | 10.57B | 8.61B | 8.48B | 7.77B | 7.15B | 8.50B | 7.81B | 6.73B | 6.50B | 6.14B | 5.62B | 5.33B | 4.74B |
| Temporary Equity (USD) | 806.00M | 864.00M | 576.00M | 613.31M | 327.70M | 287.26M | 312.16M | 832.14M | 607.64M | 542.19M | 564.53M | 497.54M | 435.18M | 402.05M |
| Equity Attributable To Parent (USD) | 3.39B | 3.66B | 3.45B | 3.43B | 3.35B | 3.00B | 2.96B | 2.81B | 2.79B | 2.88B | 2.81B | 2.79B | 2.61B | 2.43B |
| Equity Attributable To Noncontrolling Interest (USD) | 638.00M | 634.00M | 649.00M | 638.07M | 636.21M | 632.09M | 580.46M | 12.91M | 7.74M | 2.56M | 2.85M | 2.80M | 2.28M | 1.40M |
| Equity (USD) | 4.03B | 4.29B | 4.10B | 4.06B | 3.98B | 3.63B | 3.54B | 2.82B | 2.80B | 2.89B | 2.82B | 2.79B | 2.62B | 2.43B |
| Redeemable Noncontrolling Interest (USD) | - | - | - | - | - | - | 312.16M | 832.14M | 607.64M | 542.19M | 564.53M | 497.54M | 435.18M | 402.05M |
| Other Non-current Liabilities (USD) | - | - | 666.00M | - | - | - | - | - | - | - | - | - | - | 246.49M |
| Long-term Debt (USD) | - | - | 1.05B | - | - | - | - | - | - | - | - | - | - | 386.34M |
| Noncurrent Liabilities (USD) | 2.58B | 2.74B | 1.71B | 1.50B | 1.18B | 1.20B | 1.43B | 1.38B | 1.03B | 928.74M | 977.72M | 788.43M | 810.25M | 632.83M |
| Other Current Liabilities (USD) | 1.54B | 1.33B | 906.00M | 867.20M | 982.12M | 892.90M | 1.71B | 1.35B | 1.05B | 882.78M | 681.60M | 509.54M | 477.67M | 459.00M |
| Wages (USD) | 303.00M | 332.00M | 314.00M | 385.38M | 295.33M | 265.21M | 279.76M | 273.00M | 266.46M | 258.42M | 237.51M | 216.63M | 207.38M | 191.17M |
| Accounts Payable (USD) | 962.00M | 1.02B | 1.00B | 1.05B | 1.01B | 880.27M | 1.23B | 1.15B | 977.25M | 1.01B | 861.00M | 824.50M | 787.66M | 621.47M |
| Current Liabilities (USD) | 2.80B | 2.68B | 2.22B | 2.31B | 2.28B | 2.04B | 3.22B | 2.78B | 2.29B | 2.15B | 1.78B | 1.55B | 1.47B | 1.27B |
| Liabilities (USD) | 5.38B | 5.42B | 3.94B | 3.80B | 3.46B | 3.23B | 4.65B | 4.15B | 3.32B | 3.08B | 2.76B | 2.34B | 2.28B | 1.90B |
| Other Non-current Assets (USD) | 5.21B | 5.17B | 4.03B | 3.60B | 3.16B | 3.02B | 3.36B | 2.73B | 2.46B | 2.36B | 2.27B | 2.10B | 1.89B | 1.80B |
| Intangible Assets (USD) | 1.02B | 916.00M | 587.00M | 667.63M | 479.43M | 572.88M | 584.24M | 669.64M | 621.18M | 592.97M | 643.74M | 417.13M | 462.18M | 409.61M |
| Fixed Assets (USD) | - | - | - | 366.46M | 342.00M | 329.65M | 382.40M | 375.00M | 333.91M | 318.48M | 311.50M | 275.89M | 273.46M | 262.09M |
| Noncurrent Assets (USD) | 6.24B | 6.09B | 4.62B | 4.64B | 3.98B | 3.92B | 4.33B | 3.78B | 3.42B | 3.27B | 3.23B | 2.79B | 2.63B | 2.47B |
| Other Current Assets (USD) | 2.05B | 2.50B | 1.91B | 1.86B | 2.28B | 1.80B | 2.20B | 2.10B | 1.68B | 1.72B | 1.59B | 1.58B | 1.50B | 1.32B |
| Inventory (USD) | 1.81B | 1.82B | 1.96B | 1.86B | 1.51B | 1.43B | 1.97B | 1.93B | 1.64B | 1.51B | 1.33B | 1.25B | 1.20B | 947.85M |
| Cash (USD) | 122.00M | 171.00M | 117.00M | 117.97M | - | - | - | - | - | - | - | - | - | - |
| Current Assets (USD) | 3.98B | 4.49B | 3.99B | 3.84B | 3.79B | 3.23B | 4.18B | 4.03B | 3.31B | 3.23B | 2.91B | 2.83B | 2.70B | 2.27B |
| Assets (USD) | 10.22B | 10.57B | 8.61B | 8.48B | 7.77B | 7.15B | 8.50B | 7.81B | 6.73B | 6.50B | 6.14B | 5.62B | 5.33B | 4.74B |
News and Insights
The global invisible orthodontics market is projected to grow from USD 9.91 billion in 2025 to USD 96.27 billion by 2034, expanding at a CAGR of 28.54%. Clear aligners dominate the product segment, with North America leading regionally and Asia-Pacific showing significant growth potential. Adults currently represent the largest age segment, while the teens segment is expected to grow rapidly. Key drivers include rising dental misalignment cases, technological advancements in 3D printing, and increased consumer awareness of aesthetic dental solutions.
A comprehensive market report on the U.S. Personal Protective Equipment market covering gowns, masks, face shields, gloves and other segments through 2033. The report provides revenue, volume, and pricing data across market segments with company share information for 2024, identifying key opportunities for market entry, expansion, and investment strategies.
The global sleeping bruxism treatment market is projected to grow from USD 652.14 million in 2025 to USD 1,132.09 million by 2033, expanding at a 7.18% CAGR. Growth is driven by rising awareness of sleep disorders, increasing stress levels, and demand for oral appliances and behavioral therapies. Occlusal splints and night guards dominate the market, while biofeedback therapy devices represent the fastest-growing segment. North America leads with 40% market share, while Asia Pacific is expected to grow fastest at 9.25% CAGR.
Zuckerman Investment Group increased its Henry Schein stake by 72,040 shares in Q3, bringing its position to 281,339 shares valued at $18.67 million. The purchase reflects confidence in Henry Schein's improving fundamentals, including 5% revenue growth to $3.3 billion, 13% non-GAAP EPS growth to $1.38, and a new $200 million efficiency plan. The company also repurchased $229 million in stock during the quarter.
Entrepreneur William Brooke Webb Jr. alleges that Henry Schein employee secretly opened a competing lab and sabotaged his business, leading to a two-volume book exposing corruption in the Oklahoma medical laboratory industry.
Henry Schein reported strong Q3 earnings, beating consensus estimates with $1.38 adjusted earnings per share and $3.34 billion in sales. The company expanded its strategic partnership with KKR and raised its fiscal 2025 guidance for earnings and sales.
Healthcare solutions distributor Henry Schein reported Q2 2025 financial results with mixed performance, experiencing revenue growth but declining profitability due to margin pressures in dental operations and increased restructuring costs.
The dental consumables market is expected to grow significantly, driven by factors like technological advancements, aging population, and rising demand for cosmetic dentistry. The U.S. is a key market, and the CAD/CAM devices segment is projected to experience the fastest growth.
Henry Schein reported mixed Q1 earnings, with adjusted EPS beating estimates but sales missing. The CEO expressed confidence in the company's business fundamentals and ongoing strategic initiatives.